Applied DNA Sciences News

424B3: Prospectus

05:44

8-K: Company Presentation

Jan 13 21:47

S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jan 11 05:06

SCHEDULE 13G: Others

Jan 4 08:52

10-K: FY2024 Annual Report

Dec 18, 2024 05:44

8-K: Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Dec 18, 2024 05:14

DEF 14A: Definitive information statements

Dec 11, 2024 05:06

DEFA14A: Others

Dec 11, 2024 05:05

S-1: General form for registration of securities under the Securities Act of 1933

Nov 19, 2024 19:21

SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(9.9%),Anson Management GP LLC(9.9%), etc.

Nov 15, 2024 06:52

PRE 14A: Preliminary proxy statements relating to merger or acquisition

Nov 15, 2024 06:03

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Bruce Grossman(Less than 1%)

Nov 14, 2024 05:20

8-K: Current report

Nov 14, 2024 00:27

8-K: Current report

Nov 8, 2024 05:38

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-AMH Equity LLC(0.0%),Leviticus Partners, L.P.(0.0%)

Nov 7, 2024 23:13

D: Filing D

Nov 7, 2024 05:33

424B5: Prospectus

Oct 31, 2024 18:11

8-K: Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Oct 31, 2024 18:06

SC 13G: Statement of acquisition of beneficial ownership by individuals-AMH Equity LLC(9.71%),Leviticus Partners, L.P.(9.71%)

Oct 3, 2024 04:39

8-K: Poll Results of 2024 Stockholders Meeting

Oct 1, 2024 04:53